Optimization strategies for percutaneous coronary intervention in calcified coronary lesions: current evidence and future directions.

IF 2.5 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Naoya Yabumoto, Yu Kataoka, Masashi Fujino, Kensuke Takagi, Shuichi Yoneda, Kazuhiro Nakao, Yasuhide Asaumi, Kenichi Tsujita, Teruo Noguchi
{"title":"Optimization strategies for percutaneous coronary intervention in calcified coronary lesions: current evidence and future directions.","authors":"Naoya Yabumoto, Yu Kataoka, Masashi Fujino, Kensuke Takagi, Shuichi Yoneda, Kazuhiro Nakao, Yasuhide Asaumi, Kenichi Tsujita, Teruo Noguchi","doi":"10.1080/14779072.2026.2686828","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>PCI for severely calcified lesions is still challenging. Calcified lesions are associated with suboptimal results and increased risks of adverse cardiovascular events after PCI. Therefore, optimized strategies for the treatment of calcified lesions are clinically needed.</p><p><strong>Areas covered: </strong>This review summarizes the current evidence on PCI for calcified lesions. It covers pathological features of calcified lesions, the role of intravascular imaging, and the applicability of a variety of lesion preparation devices. In addition, this review discusses the efficacy and limitations of pharmacological therapies for calcified lesions.</p><p><strong>Expert opinion: </strong>A broad range of calcified plaque modification devices is currently available, and high-resolution intravascular imaging has enabled detailed assessment of calcified plaque morphology <i>in vivo</i>. The combination of appropriate devices and intravascular imaging will further improve not only acute procedural success but clinical outcomes after PCI for calcified lesions. However, important challenges remain, including limited calcified lesion-specific evidence, the lack of universally validated optimization criteria, and the absence of a standardized treatment algorithm. Further investigation is warranted to establish practical and evidence-based therapeutic approaches for calcified lesions.</p>","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"533-548"},"PeriodicalIF":2.5000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Cardiovascular Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14779072.2026.2686828","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: PCI for severely calcified lesions is still challenging. Calcified lesions are associated with suboptimal results and increased risks of adverse cardiovascular events after PCI. Therefore, optimized strategies for the treatment of calcified lesions are clinically needed.

Areas covered: This review summarizes the current evidence on PCI for calcified lesions. It covers pathological features of calcified lesions, the role of intravascular imaging, and the applicability of a variety of lesion preparation devices. In addition, this review discusses the efficacy and limitations of pharmacological therapies for calcified lesions.

Expert opinion: A broad range of calcified plaque modification devices is currently available, and high-resolution intravascular imaging has enabled detailed assessment of calcified plaque morphology in vivo. The combination of appropriate devices and intravascular imaging will further improve not only acute procedural success but clinical outcomes after PCI for calcified lesions. However, important challenges remain, including limited calcified lesion-specific evidence, the lack of universally validated optimization criteria, and the absence of a standardized treatment algorithm. Further investigation is warranted to establish practical and evidence-based therapeutic approaches for calcified lesions.

经皮冠状动脉介入治疗钙化冠状动脉病变的优化策略:目前的证据和未来的方向。
简介:PCI治疗严重钙化病变仍然具有挑战性。钙化病变与PCI术后不良心血管事件的风险增加和次优结果相关。因此,临床上需要优化钙化病变的治疗策略。涵盖领域:本综述总结了目前PCI治疗钙化病变的证据。它涵盖了钙化病变的病理特征,血管内成像的作用,以及各种病变准备装置的适用性。此外,本文还讨论了钙化病变的药物治疗的疗效和局限性。专家意见:目前有广泛的钙化斑块修饰装置可用,高分辨率血管内成像可以详细评估体内钙化斑块的形态。适当的器械和血管内成像的结合不仅会进一步提高急性手术的成功率,而且会进一步提高PCI治疗钙化病变后的临床结果。然而,重要的挑战仍然存在,包括有限的钙化病变特异性证据,缺乏普遍有效的优化标准,以及缺乏标准化的治疗算法。进一步的研究为钙化病变建立切实可行的循证治疗方法是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Cardiovascular Therapy
Expert Review of Cardiovascular Therapy CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.70
自引率
0.00%
发文量
82
期刊介绍: Expert Review of Cardiovascular Therapy (ISSN 1477-9072) provides expert reviews on the clinical applications of new medicines, therapeutic agents and diagnostics in cardiovascular disease. Coverage includes drug therapy, heart disease, vascular disorders, hypertension, cholesterol in cardiovascular disease, heart disease, stroke, heart failure and cardiovascular surgery. The Expert Review format is unique. Each review provides a complete overview of current thinking in a key area of research or clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书